Upload Avatar (500 x 500)
Honglin Yan
Medical School
Wuhan University
Hubei
Language: Chinese, English
Breast Cancer
Tumor Microenvironment
Neoadjuvant Chemotherapy
Efficacy Markers
Nervous System
Disease Pathogenesis
Predictive Markers
Cancer Research
Clinical Pathology
Molecular Diagnostics
Areas of Focus
- Breast cancer tumor microenvironment
- Predictive markers of neoadjuvant chemotherapy efficacy
- Pathogenesis of nervous system diseases
Work Experience
- 2022/12 - Present: Associate Professor, Associate Chief Technician, Department of Pathology, Renmin Hospital, Wuhan University
- 2017/12 - Present: Associate Chief Technician, Department of Pathology, Renmin Hospital, Wuhan University
- 2015/12 - 2017/11: Supervisor Technician, Department of Pathology, Renmin Hospital, Wuhan University
- 2015/07 - 2015/11: Technician, Department of Pathology, Renmin Hospital, Wuhan University
Academic Background & Achievements
- 2011.09 - 2015.06: PhD in Pathology and Pathophysiology, Tongji Medical College, Huazhong University of Science and Technology
- Bachelor of Science in Biopharmaceuticals, Henan University of Technology (2007.09 - 2011.06)
- Presided over one National Natural Science Foundation of China, one Natural Science Foundation of Hubei Province, and one Fundamental Research Funds for the Central Universities
Publications
- Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate ischemic neuronal death by targeting miR-21/PDCD4 signaling pathway, Honglin Yan, Jie Rao, Jingping Yuan, Likun Gao, Wenxian Huang, Lina Zhao, Jiacai Ren, 2017
- Intervention of death-associated protein kinase 1-p53 interaction exerts the therapeutic effects against stroke, Xiaoxi Wang, Lei Pei, Honglin Yan, Zhongping Wang, Na Wei, Shan Wang, Xin Yang, Qing Tian, Youming Lu, 2014
- Cisplatin Induces Pyroptosis via Activation of MEG3/NLRP3/caspase-1/GSDMD Pathway in Triple-Negative Breast Cancer, Honglin Yan, Bin Luo, Xiaoyan Wu, Feng Guan, Xinxin Yu, Lina Zhao, Xiaokang Ke, Juan Wu, Jingping Yuan, 2021
- Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients, Jingping Yuan, Huihua He, Chuang Chen, Juan Wu, Jie Rao, Honglin Yan, 2019
- miR-21 regulates ischemic neuronal injury via the p53/Bcl-2/Bax signaling pathway, Honglin Yan, Wenxian Huang, Jie Rao, Jingping Yuan, 2021
Awards
- 2022: Third Prize, Hubei Provincial Higher Education Teaching Achievement Award
- 2021: Third Prize, Hubei Provincial Science and Technology Progress Award
- 2021: Second Prize, Wuhan University Teaching Achievement Award
